Evidence map›Paper›PMID 41148546›Full record

ReviewAging clinical and experimental research2025

Late-onset alzheimer's disease, atherosclerosis, and cerebrovascular disease. A complex relationship too often neglected: a narrative review.

Giovanni Zuliani, Carlo Cervellati

Abstract readReview
In one paragraph

Review in Aging clinical and experimental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Giovanni ZulianiDepartment of Translational Medicine and for Romagna, University of Ferrara, via L- Borsari 26, 44121, Ferrara, Italy.
Carlo CervellatiDepartment of Translational Medicine and for Romagna, University of Ferrara, via L- Borsari 26, 44121, Ferrara, Italy. crvcrl@unife.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the 1990s, a long series of preclinical, epidemiological, clinical, and anatomo-pathological studies have questioned the purely "degenerative" origin of Alzheimer's disease (AD), providing growing evidence of a possible "vascular" involvement in the pathogenesis of this type of dementia.Currently, evidence accumulated from preclinical, epidemiological, anatomo-pathological, clinical, neuroimaging, and proteomic studies supports a significant role of cerebral atherosclerosis in the pathogenesis of late-onset sporadic AD (LOAD). It is now well established that cerebral atherosclerosis, through various mechanisms, can promote the deposition of β-amyloid, as well as cause alterations in energy metabolism and neuronal damage.Conversely, β-amyloid can induce not only inflammation and oxidative stress, but also changes in cerebral hemodynamics, pathological angiogenesis, and endothelial dysfunction, thereby contributing to the development of cerebral atherosclerosis.Consistent data suggest that vascular phenomena may precede neurodegenerative ones. In any case, a dangerous vicious cycle is created, in which a clear separation between degenerative and vascular processes is sometimes extremely difficult to establish.

Indexed as

Alzheimer DiseaseAtherosclerosisCerebrovascular DisordersAmyloid beta-PeptidesHumansOxidative StressAmyloid beta-PeptidesAlzheimer’s diseaseAtherosclerosisVascula dementiaβ-amyloid

Identifiers

PMID41148546
PMCPMC12568846

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.